Abstract
Chronic inflammation is a feature of the airways of patients exhibiting lung diseases such as asthma, sarcoidosis and bronchitis. This has been recognised from autopsy studies of asthmatic airways (1) and has also been shown to be evident in the airways of asthmatics who have mild asthma (2) or are asymptomatic (3). Bronchial airway hyperreactivity (BHR) to a wide range of pharmacological and physical agents is one of the most characteristic features of asthmatic airways. It is known that intensification of BHR follows antigen challenge in atopic asthmatics (4) and it has been widely presumed that inflammatory events during late-onset reactions may determine the changes in airway reactivity (5).
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Dunnill, M.S. 1960. The pathology of asthma, with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 13: 27–33.
Laitinen, L.A., M. Heino, A. Laitinen, T. Kava, and T. Haahtela. 1985. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am. Rev. Respir. Dis. 131: 599–606.
Beasley, R., W.R. Roche, G.A. Roberts, and S.T. Holgate. 1989. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139: 806–817.
Cockcroft, D.W., R.E. Ruffm, J. Dolovich, and F.E. Hargreave. 1977. Allergen induced increase in non-allergic bronchial reactivity. Clin. Allergy 7: 503–513.
Chung, K.F. 1986. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax 41: 657–662.
Frigas, E., and G.J. Gleich. 1986. The eosinophil and the pathophysiology of asthma. J. Allergy Clin. Immunol. 77: 527–537.
Horn, B.R., E.D. Robin, J. Theodore, and A. Van Kessel. 1975. Total eosinophil counts in the management of asthma. New Engl. J. Med. 292: 1152–1155.
De Monchy, J.G.R., H.F. Kauffman, P. Venge, G.H. Koeter, H.M. Jansen, J. Suiter, and K. de Vries. 1985. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 131: 373–376.
Booij-Noord, H.J., N.G.M. Orie, and K. de Vries. 1971. Immediate and late bronchial obstructive reactions to inhalations of house dust and protective effects of disodium cromoglycate and prednisolone. J. Allergy Clin. Immunol. 48: 344–354.
Durham, S.R., and A.B. Kay. 1985. Eosinophils, bronchial hyperreactivity and late phase asthmatic reactions. Clin. Allergy 15: 411–418.
Barnes, PJ., K.F. Chung, and C.P. Page. 1988. Inflammatory mediators in asthma. Pharmacol. Rev 40: 49–84.
Gleich, G.J., and C.R. Adolphson. 1986. The eosinophilic leukocyte: structure and function. Adv. Immunol. 39: 177–182.
Gleich, G.J., E. Frigas, D.A. Loegering, D.L. Wasson, and D. Steinmuller. 1979. Cytotoxic effects of the eosinophil major basic protein. J. Immunol. 123: 2925–2927.
Frigas, E., D.A. Loegering, G.O. Solley, G.M. Farrow, and G.J. Gleich. 1981. Elevated levels of eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clinic. Proc. 56: 345–353.
Flavahan, N.A., N.R. Slifman, G.J. Gleich, and P.M. Vanhoutte. 1988. Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle: Role of the epithelium. Am. Rev. Respir. Dis. 138: 685–688.
Frigas, E., D.A. Loegering, and G.J. Gleich. 1980. Cytotoxic effects of the guinea-pig eosinophil major basic protein on tracheal epithelium. Lab. Invest. 42: 35–43.
Henocq, E., and B.B. Vargaftig. 1988. Skin eosinophilia in atopic patients. J. Allergy Clin. Immunol. 81: 691–695.
Cuss, F.M., C.M.S. Dixon, and PJ. Barnes. 1986. Effects of inhaled platelet-activating factor on pulmonary function and bronchial responsiveness in man. Lancet 2: 189–192.
Sanjar, S., S. Aoki, K. Boubekeur, I.D. Chapman, D. Smith, M.A. Kings, and J. Morley. 1990. Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: Effect of anti-asthma drugs. Br. J. Pharmacol. 99: 267–272.
Coyle, A.J., S.C. Urwin, C.P. Page, C. Touvay, B. Villain, and P. Braquet. 1988. The effect of the selective PAF antagonist BN 52021 on PAF-induced and antigen-induced bronchial hyperreactivity and eosinophil accumulation. Eur. J. Pharmacol. 148: 51–58.
Basten, A., and P.B. Beeson. 1970. Mechanism of eosinophilia. II. Role of the lymphocyte. J. Exp. Med. 131: 1288–1294.
Vadas, M.A., A.F. Lopez, M.F. Shannon, and I. Clark-Lewis. 1989. Regulation of eosinophilopoiesis in man. In Eosinophils in Asthma. J. Morley, and I.G. Colditz, editors. Academic Press, London. 1–11.
Baggiolini, M., A. Walz, S.L. Kunkel. 1990. Neutrophil activating peptide -1/interleukin 8, a novel cytokine that activates human neutrophils. J. Clin. Invest. 84: 1045–1050.
Bacon, K.B., J. Westwick, and R.D.R. Camp. 1989. Potent and specific inhibition of IL-8, IL-1α- and IL-1β-induced in vitro human lymphocyte migration by calcium channel antagonists. Biochem. Biophys. Res. Commun. 165: 349–354.
Larsen, C.G., A.O. Anderson, A. Apella, J.J. Oppenheim, and K. Matsushima. 1989. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243: 1464–1466.
Corrigan, C.J., A. Hartnell, and A.B. Kay. 1988. T Lymphocyte activation in acute severe asthma Lancet i, 1129–1132.
Strieter, R.M., S.L. Kunkel, H.J. Showell, and R.M. Marks. 1988. Monokine-induced gene expression of a human endothelial cell derived neutrophil chemotactic factor. Biochem. Biophys. Res. Commun. 156: 1340–1345.
Eber, V.M., R.M. Strieter, S.G. Einer, M. Baggiolini, I. Lindley, and S.L. Kunkel. 1990. Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am. J. Pathol. 136: 4, 745–750.
Richerson, H.B. 1972. Acute experimental hypersensitivity pneumonitis in the guinea-pig. J. Lab. Clin. Med. 79: 745–757.
Sanjar, S., S. Aoki, A. Kristersson, D. Smith, and J. Morley. 1990. Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitised guinea-pigs: the effect of anti-asthma drugs. Br. J. Pharmacol. 99: 679–686.
Maccia, C.A. 1977. Platelet thrombopathy in asthmatic patients with elevated immunoglobulin E. J. Allergy Clin. Immunol. 59: 101–108.
Gallagher, J.S., I.L. Bernstein, C.A. Maccia, G.L. Splansky, and H.I. Glueck. 1978. Cyclic platelet dysfunction in IgE-mediated allergy. J. Allergy Clin. Immunol. 62: 229–235.
Slater, D.N., J.F. Martin, and E.A. Trowbridge. 1985. The platelet in asthma. Lancet i:110–111.
Knauer, K.A., L.M. Lichenstein, N.F. Adkinson, and J.E. Fish. 1981. Platelet activation during antigen-induced airway reactions in asthmatic subjects. New Engl. J. Med. 304: 1404–1407.
Gresele, P., T. Todisco, F. Merante, and G.G. Nenci. 1982. Platelet activation and allergic asthma. New Engl. J. Med. 306: 549–549.
Walz, A., and M. Baggiolini. 1990. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases. J. Exp. Med. 171: 449–454.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Smith, D., Burrows, L., Westwick, J. (1991). Interleukin-8 —A Mediator of Inflammatory Lung Disease?. In: Westwick, J., Lindley, I.J.D., Kunkel, S.L. (eds) Chemotactic Cytokines. Advances in Experimental Medicine and Biology, vol 305. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-6009-4_14
Download citation
DOI: https://doi.org/10.1007/978-1-4684-6009-4_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-6011-7
Online ISBN: 978-1-4684-6009-4
eBook Packages: Springer Book Archive